Anavar: Strength, Doses and Side Effects

Anavar, at a glance

People take Anavar hoping to keep strength and a fuller, more defined look while cutting. Its tablet form is convenient; its “mild” reputation can hide substantial cholesterol, liver and hormone trade-offs.

A better gym pump is not the same as lasting muscle gain. Human studies show anabolic effects, but results after stopping and the population studied matter.

Reported doses & duration ↗ Compare with Winstrol ↗

One trial · 32 men aged 60–87 · oxandrolone versus placebo

1. 12 weeks on treatment Lean mass & strength increased

   The trial used 20 mg/day. Total body water also increased.

2. 12 weeks after stopping Gains were no longer significantly above baseline

   The follow-up matters as much as the end-of-treatment photo.

A study of older men, not a forecast for younger lifters or a recommended course. Original trial

Reported doses and cycle lengths

The numbers below describe different sources and populations. They are not a safe starting-dose ladder, and a lower women’s range does not guarantee freedom from masculinizing effects.

Other contexts, kept separate: one nonmedical proposal described 40–50 mg/day for six weeks, with no daily split specified. The historical adult medical label instead described 2.5–20 mg/day in 2–4 divided doses, with 2–4 weeks usually adequate for its medical uses.

Mullen’s 2020 review, Table 1 explicitly compiled online reports and supplier information. It did not test those amounts. That nonmedical example is a proposed course, not a studied regimen or completed safety study. The old label describes historical medical treatment—not bodybuilding use or current US approval.

Total per day is not per tablet or per administration. Splitting a total into two parts does not double it. Do not combine a dose range from one row with a duration from another and call it a tested regimen. Four or six weeks is not a proven safety threshold.

What strength and physique changes have been measured?

In a randomized trial of 32 men aged 60–87, oxandrolone at 20 mg/day for 12 weeks increased lean mass, muscle size and strength compared with placebo, while fat mass decreased. Total body water also increased, so the lean-mass result should not be described as pure new muscle. Twelve weeks after stopping, lean body mass and strength were no longer significantly above starting levels. Original follow-up study.

A report from the same cohort specifies 10 mg twice daily and found improvements in several lifts by six weeks, without better walking speed or leg power. It is not a second independent trial. Six-week analysis.

In a separate study of 29 older women, 10 mg/day plus resistance training for 12 weeks improved body composition more than training with placebo, but did not add strength or functional benefits. These results show real anabolic effects in particular settings; they do not predict results in a younger trained lifter. Women’s randomized trial.

Does it help with cutting rather than bulking?

Its popularity during a cut comes from the desire to preserve strength and muscle appearance while body weight falls. People also use it during muscle-gain phases. The distinction is the goal and overall exposure, not a switch that makes oxandrolone work only in a calorie deficit.

The older-men trial found fat-mass changes, so saying “it can never affect body fat” is too broad. Equally, those findings do not make it a proven weight-management treatment or establish a predictable result in healthy young athletes. A stronger gym pump does not measure fat loss or lasting muscle gain. See Anavar vs Winstrol for the common oral-steroid comparison.

The oral-steroid trade-offs

• Cholesterol: HDL can fall and LDL can rise. These changes may not feel like anything; looking lean or training well does not reveal the lipid panel.
• Liver: oxandrolone is a 17-alpha-alkylated oral steroid. Its historical label warns about cholestatic hepatitis, jaundice and serious liver complications, including at relatively low amounts. A liver-support supplement does not make those warnings disappear.
• Hormones: natural testosterone production and sperm production can be suppressed. An oral-only course does not avoid that pathway, and a libido change cannot confirm recovery.
• Warfarin: the historical label reports a substantial interaction that can increase anticoagulant effects and bleeding. This needs clinical medication review.
• Training discomfort: painful “pumps” and cramping are recurring user reports. Do not assume severe or persistent pain is harmless because someone else called it a pump.

The first four concerns are documented in the historical product information; the training descriptions are self-reported experiences, not findings from that label. Review blood pressure, the full lab results, symptoms and other medicines together. The historical label calls for stopping oxandrolone if jaundice or abnormal liver tests occur, with medical assessment of the cause. Dark urine or significant abdominal pain also needs prompt assessment. Reading bloodwork explains what the separate markers mean.

What is different for women?

Some women also describe strength and definition as their goals. Reported experiences include hair shedding and other unwanted changes. The attraction of a lower reported amount should not be confused with a validated safe threshold.

Stop oxandrolone and contact a clinician promptly at early signs of virilization, such as voice changes, increased facial hair or clitoral changes. The historical label says some changes can be irreversible even after prompt discontinuation. Acne and menstrual changes also warrant review. Do not use an unverified rule about “safe female doses” to decide that a new change can be ignored.

Product identity and the old prescription label

US approval of Oxandrin and several generic oxandrolone applications was withdrawn in 2023. FDA’s October 7, 2026 correction explicitly includes the referenced generic products in its safety-or-effectiveness withdrawal determination. It is not a reapproval. FDA correction.

An old DailyMed page therefore does not establish that a tablet sold today is an approved US product. Price, packaging and how a tablet feels are not reliable identity tests. A chemical report applies to its submitted sample and measured contents; it does not prove every tablet or establish clinical safety.

Timing and the plotter

Use the oxandrolone curve to compare the overlap from a stated schedule, with its model notes visible. A lower trough does not prove that another tablet is needed, and a peak does not establish the best pre-workout time. The clinical twice-daily example above is evidence of what that study did, not proof that split dosing is better for every goal.

Common questions

Is Anavar the same as Anadrol?

No. Anavar is oxandrolone; Anadrol is oxymetholone. Similar names do not make their amounts or effects interchangeable.

Does a dry look mean hormones and fluid balance are normal?

No. Appearance cannot diagnose estradiol or establish that natural testosterone production is preserved. New breast symptoms or swelling need assessment rather than assuming a tablet cannot be involved.

Can half-life tell me when a drug test will be negative?

No. Analytical tests can target metabolites, and the result depends on the method and exposure history. A concentration curve is not a detection countdown.

Source scope and medication interaction

The two older-men publications describe the same 32-person trial. The older-women study had a different population and a resistance-training intervention, so its results are not a head-to-head comparison between sexes. Reported-use numbers are kept separate from both studies and from the discontinued medical label.

The historical label also documents a substantial warfarin interaction, including increased anticoagulant effect and bleeding. Any medication review needs that information even when the person feels well. Sources rechecked October 12, 2026. No model default supplied a dose or cycle length.